Showing 2071 - 2080 of 2133 for "Copyright & related rights" with applied filters
Filters:
18 May 2019 by Managing Intellectual Property
Congratulations to all the 2019 US IP stars, particularly those featured for the first time
26 April 2019 by Managing Intellectual Property
The 2019 rankings of the leading firms for copyright work in more than 40 jurisdictions are now available on ipstars.com
11 April 2019 by Kingsley Egbuonu
The firm welcomed a team from a small boutique firm in the UAE
08 April 2019 by Managing Intellectual Property
Managing IP has published the list of all the winners announced at its awards ceremonies in March and April
19 December 2018 by Kingsley Egbuonu
The Luxembourg-based law firm announced in November 2018 that it has joined the PwC network ‘as an independent law firm’
12 December 2018 by Managing Intellectual Property
Managing IP is delighted to announce the launch of its official Rising Stars publication
03 December 2018 by Alexander Korenberg and Tom Hamer
Alexander Korenberg and Tom Hamer of Kilburn & Strode analyse the EPO's new guidelines on artificial intelligence and machine learning
31 October 2018 by Kingsley Egbuonu
This roundup includes Nelson Mullins Broad and Cassel, Kilpatrick Townsend & Stockton, Venable, Kacvinsky Daisak Bluni, Oblon, Shearman & Sterling, Alessandri, Maucher Jenkins, Hoyng Rokh Monegier, AWA, Venner Shipley, Mewburn Ellis, Page White and Farrer, Bird & Bird, Dittmar & Indrenius, Mathys & Squire, Baker McKenzie Habib Al Mulla, and Simone Intellectual Property Services Asia (SIPS).
29 October 2018 by Alexander Korenberg and Tom Hamer
The EPO has issued new Guidelines for Examination covering a range of issues such as the removal or replacement of a feature in a claim, inventive step attacks in oppositions and summons to oral proceedings. Tom Hamer and Alexander Korenberg of Kilburn & Strode assess whether applicants will welcome the changes
24 September 2018 by Frances Salisbury and Adam Gregory
Novartis and the NHS’ recent agreement concerning CAR-T therapy is a positive step for adoptive immunotherapy. However, while the future looks bright, the therapy is also subject to threats. Frances Salisbury and Adam Gregory of Mewburn Ellis discuss successes and potential Brexit-related hurdles
